reference/8170962

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/8170962

Outgoing Links

Predicate	Object
contentType	Journal Article\|Randomized Controlled Trial
issn	1742-1241 1368-5031
issueIdentifier	5
pageRange	e13480-
publicationName	International Journal of Clinical Practice
startingPage	e13480
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_8075d9d563cbe75004e7b6c2c4360b29 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e1799456388a158d525bdd839a50160b
bibliographicCitation	Roehrborn CG, Rosen RC, Manyak MJ, Palacios-Moreno JM, Wilson TH, Lulic Z, Giuliano F. Men's Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo-controlled study. Int J Clin Pract. 2020 May;74(5):e13480. PMID: 31927774; PMCID: PMC7187250.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d0c11e15977ab8109654849ec0592a87 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_be2e26ddee3dd1026b7f639e20fdb06c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ea7864a4806c9ea0008695a484dc292f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1c80d0dc7f64d58777889c1b9efd4d51 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f2a0709c0f4f99482e34dff2453737c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_922fb7e5b1dc033e4233e6d1505e3416 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-9946-4005
date	202005
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC7187250 https://pubmed.ncbi.nlm.nih.gov/31927774 https://doi.org/10.1111/ijcp.13480
isPartOf	https://portal.issn.org/resource/ISSN/1742-1241 https://portal.issn.org/resource/ISSN/1368-5031 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/20688
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Men’s Sexual Health Questionnaire score changes vs spontaneous sexual adverse event reporting in men treated with dutasteride/tamsulosin combination therapy for lower urinary tract symptoms secondary to benign prostatic hyperplasia: A post hoc analysis of a prospective, randomised, placebo‐controlled study
discusses	http://id.nlm.nih.gov/mesh/M0234193 http://id.nlm.nih.gov/mesh/M0281571
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D000077409Q000009 http://id.nlm.nih.gov/mesh/D059411Q000188 http://id.nlm.nih.gov/mesh/D000074384 http://id.nlm.nih.gov/mesh/D000068538Q000009 http://id.nlm.nih.gov/mesh/D011470Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012725 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D011446 http://id.nlm.nih.gov/mesh/D054526 http://id.nlm.nih.gov/mesh/D059411Q000209 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D011795 http://id.nlm.nih.gov/mesh/D007989Q000187 http://id.nlm.nih.gov/mesh/D004542Q000187 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D011470Q000150 http://id.nlm.nih.gov/mesh/D000077409Q000627 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D000068538Q000627 http://id.nlm.nih.gov/mesh/D010410
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_ffa044f5d18974a3264c23a5e1e06217 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8982 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918296 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID129211 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11347

Total number of triples: 56.